Truist Financial’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,079
| Closed | -$270K | – | 2745 |
|
|
2024
Q2 | $270K | Sell |
32,079
-1,379
| -4% | -$11.6K | ﹤0.01% | 2332 |
|
|
2024
Q1 | $483K | Sell |
33,458
-5,038
| -13% | -$72.7K | ﹤0.01% | 1974 |
|
|
2023
Q4 | $828K | Buy |
38,496
+8,247
| +27% | +$177K | ﹤0.01% | 1693 |
|
|
2023
Q3 | $581K | Sell |
30,249
-731
| -2% | -$14.1K | ﹤0.01% | 1836 |
|
|
2023
Q2 | $788K | Sell |
30,980
-1,338
| -4% | -$34K | ﹤0.01% | 1698 |
|
|
2023
Q1 | $1.17M | Buy |
32,318
+218
| +0.7% | +$7.88K | ﹤0.01% | 1474 |
|
|
2022
Q4 | $1.27M | Buy |
32,100
+8,994
| +39% | +$356K | ﹤0.01% | 1437 |
|
|
2022
Q3 | $1.08M | Sell |
23,106
-8,873
| -28% | -$414K | ﹤0.01% | 1457 |
|
|
2022
Q2 | $1.4M | Buy |
31,979
+9,032
| +39% | +$396K | ﹤0.01% | 1383 |
|
|
2022
Q1 | $1.66M | Sell |
22,947
-5,368
| -19% | -$388K | ﹤0.01% | 1372 |
|
|
2021
Q4 | $2.3M | Sell |
28,315
-8,027
| -22% | -$651K | ﹤0.01% | 1227 |
|
|
2021
Q3 | $4.23M | Sell |
36,342
-813
| -2% | -$94.6K | 0.01% | 944 |
|
|
2021
Q2 | $6.16M | Buy |
37,155
+5,099
| +16% | +$845K | 0.01% | 797 |
|
|
2021
Q1 | $4.47M | Buy |
32,056
+8,148
| +34% | +$1.14M | 0.01% | 876 |
|
|
2020
Q4 | $4.14M | Buy |
23,908
+4,127
| +21% | +$714K | 0.01% | 874 |
|
|
2020
Q3 | $2.76M | Buy |
19,781
+3,562
| +22% | +$496K | 0.01% | 943 |
|
|
2020
Q2 | $1.94M | Buy |
16,219
+2,485
| +18% | +$297K | ﹤0.01% | 1039 |
|
|
2020
Q1 | $1.37M | Sell |
13,734
-844
| -6% | -$84.4K | ﹤0.01% | 1125 |
|
|
2019
Q4 | $1.71M | Buy |
+14,578
| New | +$1.71M | ﹤0.01% | 1191 |
|